Science Explorer Back to mapMap
Discussion
Researcher · Oncomatryx (Spain) · Spain

Myriam Fabre

Myriam Fabre publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Peptidase Inhibition and Analysis, Cancer Cells and Metastasis and Wnt/β-catenin signaling in development and cancer.

OpenAlex
World rank
#2,153,607
of 7,710,434 ranked researchers
Rank in Spain
#46,510
of 204,306
Works
64
Citations
1.8k
Citations per work
27.8
h-index
19
i10-index 30Top 36% in Molecular Biology
Myriam Fabre

What does Myriam Fabre research?

Myriam Fabre's work is mostly in Biochemistry, Genetics and Molecular Biology (39%), Medicine (19%), Immunology and Microbiology (4%).

Life Sciences: 28 works · 43.4% of their workBiochemistry, Genetics and Molecular Biology: 25 works · 39.3% of their workMolecular Biology: 23 works · 35.2% of their workCell Biology: 3 works · 4.1% of their workImmunology and Microbiology: 3 works · 4.1% of their workImmunology: 3 works · 4.1% of their workEverything else: 22 works · 34.4% of their workHealth Sciences: 12 works · 19.4% of their workMedicine: 12 works · 19.4% of their workOncology: 11 works · 16.6% of their workPulmonary and Respiratory Medicine: 2 works · 2.8% of their workPhysical Sciences: 2 works · 2.8% of their workEngineering: 2 works · 2.8% of their workBiomedical Engineering: 2 works · 2.8% of their workTHEIR WORKMyriam Fabre64works
Life Sciences43%Physical Sciences3%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2539.3%
    2. Immunology and Microbiology34.1%
  2. Everything else2234.4%
    1. Medicine1219.4%
    1. Engineering22.8%
  1. 1Molecular Biology35% of their works
  2. 2Oncology17% of their works
  3. 3Immunology4% of their works
  4. 4Cell Biology4% of their works
  5. 5Biomedical Engineering3% of their works
  6. 6Pulmonary and Respiratory Medicine3% of their works

Research topics

Which keywords describe Myriam Fabre's research?

The keywords of their largest research topics: Cancer, Tumor Microenvironment, Cancer Therapy, Epigenetic Regulation, Transcriptional Regulation, Fibroblast Activation Protein, Immunosuppression and Cancer Stem Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Cancer143 topics
  2. Tumor Microenvironment132 topics
  3. Cancer Therapy122 topics
  4. Epigenetic Regulation92 topics
  5. Transcriptional Regulation92 topics
  6. Fibroblast Activation Protein81 topic
  7. Immunosuppression81 topic
  8. Cancer Stem Cells61 topic
  9. Tumor Metastasis61 topic
  10. Arginine Methylation51 topic
  11. Immune Checkpoint Blockade51 topic
  12. PD-1 and PD-L151 topic
  13. Protein Arginine Methyltransferases51 topic
  14. Wnt Signaling51 topic
  15. ß-Catenin51 topic
  16. BET Bromodomains41 topic
  17. Glycans41 topic
  18. Glycosylation41 topic
  19. HDAC Inhibitors41 topic
  20. Histone Deacetylases41 topic
  21. PROTACs41 topic

Where does Myriam Fabre work?

Myriam Fabre's main affiliation in the publication record is Oncomatryx (Spain), Spain.

How many publications and citations does Myriam Fabre have?

OpenAlex counts 64 works and 1,782 citations for Myriam Fabre, an h-index of 19, ranking #2,153,607 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Myriam Fabre. Posts are plain text and can be reported.